These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18719758)

  • 1. Heart rate dynamics during a treadmill cardiopulmonary exercise test in optimized beta-blocked heart failure patients.
    Carvalho VO; Guimarães GV; Ciolac EG; Bocchi EA
    Clinics (Sao Paulo); 2008 Aug; 63(4):479-82. PubMed ID: 18719758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate dynamics in heart transplantation patients during a treadmill cardiopulmonary exercise test: a pilot study.
    Carvalho VO; Pascoalino LN; Bocchi EA; Ferreira SA; Guimarães GV
    Cardiol J; 2009; 16(3):254-8. PubMed ID: 19437401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate dynamic during an exercise test in heart failure patients with different sensibilities of the carvedilol therapy: heart rate dynamic during exercise test.
    Carvalho VO; Rodrigues Alves RX; Bocchi EA; Guimarães GV
    Int J Cardiol; 2010 Jun; 142(1):101-4. PubMed ID: 19155077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between heart rate reserve and oxygen uptake reserve in heart failure patients on optimized and non-optimized beta-blocker therapy.
    Carvalho VO; Guimarães GV; Bocchi EA
    Clinics (Sao Paulo); 2008 Dec; 63(6):725-30. PubMed ID: 19060991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The carvedilol's beta-blockade in heart failure and exercise training's sympathetic blockade in healthy athletes during the rest and peak effort.
    Carvalho VO; Bocchi EA; Guimarães GV
    Cardiovasc Ther; 2010 Apr; 28(2):87-92. PubMed ID: 20398097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).
    Blanchet M; Ducharme A; Racine N; Rouleau JL; Tardif JC; Juneau M; Marquis J; Larivée L; Nigam A; Fortier A; White M
    Am J Cardiol; 2003 Sep; 92(5):548-53. PubMed ID: 12943875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different impact of carvedilol and transdermal scopolamine on cardiovascular performance of mild-moderate chronic heart failure patients: evidence of useful effects of scopolamine on tolerance to work load.
    De Vecchis R; Pucciarelli G; Setaro A; Nocerino L
    Minerva Cardioangiol; 2000 Nov; 48(11):393-410. PubMed ID: 11214431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of carvedilol on oxygen uptake and heart rate kinetics in patients with chronic heart failure at simulated altitude.
    Karsten M; Contini M; Cefalù C; Cattadori G; Palermo P; Apostolo A; Bussotti M; Magrì D; Salvioni E; Farina S; Sciomer S; Catai AM; Agostoni P
    Eur J Prev Cardiol; 2012 Jun; 19(3):444-51. PubMed ID: 21450573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Gackowski A; Piwowarska W; Stepniewski M
    Kardiol Pol; 2008 Feb; 66(2):144-51; discussion 152-3. PubMed ID: 18344152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.
    Hirsh BJ; Mignatti A; Garan AR; Uriel N; Colombo P; Sims DB; Jorde UP
    Circ Heart Fail; 2012 Sep; 5(5):560-5. PubMed ID: 22855557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial).
    Volterrani M; Cice G; Caminiti G; Vitale C; D'Isa S; Perrone Filardi P; Acquistapace F; Marazzi G; Fini M; Rosano GM
    Int J Cardiol; 2011 Sep; 151(2):218-24. PubMed ID: 21764469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonselective beta-adrenergic blocking agent, carvedilol, improves arterial baroflex gain and heart rate variability in patients with stable chronic heart failure.
    Mortara A; La Rovere MT; Pinna GD; Maestri R; Capomolla S; Cobelli F
    J Am Coll Cardiol; 2000 Nov; 36(5):1612-8. PubMed ID: 11079666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
    Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of 6 months of therapy with carvedilol on muscle sympathetic nerve activity in heart failure patients.
    De Matos LD; Gardenghi G; Rondon MU; Soufen HN; Tirone AP; Barretto AC; Brum PC; Middlekauff HR; Negrão CE
    J Card Fail; 2004 Dec; 10(6):496-502. PubMed ID: 15599840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited predictive value of cardiopulmonary exercise indices in patients with moderate chronic heart failure treated with carvedilol.
    Corrà U; Mezzani A; Bosimini E; Scapellato F; Temporelli PL; Eleuteri E; Giannuzzi P
    Am Heart J; 2004 Mar; 147(3):553-60. PubMed ID: 14999209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of beta-blockers on ventilation efficiency in heart failure.
    Agostoni P; Apostolo A; Cattadori G; Salvioni E; Berna G; Antonioli L; Vignati C; Schina M; Sciomer S; Bussotti M; Palermo P; Fiorentini C; Contini M
    Am Heart J; 2010 Jun; 159(6):1067-73. PubMed ID: 20569721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of carvedilol on the benefits of physical training in patients with moderate chronic heart failure.
    Forissier JF; Vernochet P; Bertrand P; Charbonnier B; Monpère C
    Eur J Heart Fail; 2001 Jun; 3(3):335-42. PubMed ID: 11378005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.